Capital Research Global Investors Has $251.29 Million Holdings in The Ensign Group, Inc. $ENSG

Posted by Geri Gentry on Jun 8th, 2026

Capital Research Global Investors lessened its stake in The Ensign Group, Inc. (NASDAQ:ENSG – Free Report) by 28.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,442,518 shares of the company’s stock after selling 573,583 shares during the quarter. Capital Research Global Investors’ holdings in The Ensign Group were worth $251,287,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Private Trust Co. NA boosted its holdings in shares of The Ensign Group by 156.5% in the fourth quarter. Private Trust Co. NA now owns 159 shares of the company’s stock valued at $28,000 after buying an additional 97 shares during the period. Northwestern Mutual Wealth Management Co. lifted its position in shares of The Ensign Group by 55.0% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 172 shares of the company’s stock worth $30,000 after purchasing an additional 61 shares in the last quarter. Harbor Investment Advisory LLC lifted its position in shares of The Ensign Group by 125.6% in the fourth quarter. Harbor Investment Advisory LLC now owns 194 shares of the company’s stock worth $34,000 after purchasing an additional 108 shares in the last quarter. Larson Financial Group LLC lifted its position in shares of The Ensign Group by 76.9% in the third quarter. Larson Financial Group LLC now owns 207 shares of the company’s stock worth $36,000 after purchasing an additional 90 shares in the last quarter. Finally, Caitlin John LLC bought a new stake in shares of The Ensign Group in the third quarter worth $39,000. Institutional investors and hedge funds own 96.12% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently commented on ENSG. Wall Street Zen lowered shares of The Ensign Group from a “buy” rating to a “hold” rating in a research report on Saturday. Zacks Research lowered shares of The Ensign Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. Weiss Ratings reissued a “buy (b)” rating on shares of The Ensign Group in a research report on Tuesday, April 21st. Finally, Royal Bank Of Canada reissued an “outperform” rating and issued a $222.00 price objective (up from $206.00) on shares of The Ensign Group in a research report on Monday, February 9th. Four research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $216.75.

Read Our Latest Report on The Ensign Group

Insider Activity

In other news, Director Barry M. Smith sold 700 shares of the stock in a transaction dated Thursday, April 2nd. The shares were sold at an average price of $196.65, for a total value of $137,655.00. Following the transaction, the director directly owned 22,152 shares of the company’s stock, valued at $4,356,190.80. This represents a 3.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director John O. Agwunobi sold 392 shares of the stock in a transaction dated Monday, April 20th. The shares were sold at an average price of $199.97, for a total transaction of $78,388.24. Following the completion of the transaction, the director directly owned 9,295 shares in the company, valued at $1,858,721.15. The trade was a 4.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,592 shares of company stock worth $478,246 over the last three months. Insiders own 4.00% of the company’s stock.

The Ensign Group Stock Performance

NASDAQ ENSG opened at $170.30 on Monday. The company has a current ratio of 1.56, a quick ratio of 1.56 and a debt-to-equity ratio of 0.06. The firm’s fifty day moving average price is $184.82 and its two-hundred day moving average price is $187.77. The Ensign Group, Inc. has a 1 year low of $134.79 and a 1 year high of $218.00. The firm has a market capitalization of $9.95 billion, a P/E ratio of 27.74, a price-to-earnings-growth ratio of 1.67 and a beta of 0.68.

The Ensign Group (NASDAQ:ENSG – Get Free Report) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.79 by $0.06. The Ensign Group had a net margin of 6.89% and a return on equity of 16.78%. The firm had revenue of $1.39 billion for the quarter, compared to analyst estimates of $1.40 billion. During the same period in the prior year, the firm posted $1.52 earnings per share. The company’s quarterly revenue was up 18.4% compared to the same quarter last year. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. As a group, research analysts anticipate that The Ensign Group, Inc. will post 6.79 EPS for the current year.

The Ensign Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st were given a dividend of $0.065 per share. This represents a $0.26 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend was Tuesday, March 31st. The Ensign Group’s dividend payout ratio is 4.23%.

The Ensign Group Profile

(Free Report)

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.